Patents by Inventor Andrew J ROBLES

Andrew J ROBLES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Altertoxin II as a selective inhibitor of Ewing family of tumor cells
    Patent number: 10874631
    Abstract: Certain embodiments are directed to methods for treating Ewing family tumors (EFT) comprising administering an effective amount of altertoxin II to a subject having EFT.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: December 29, 2020
    Assignees: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
    Inventors: Susan L Mooberry, Andrew J Robles, April L Risinger, Robert H Cichewicz, Saikat Haldar, Peter Houghton
  • ALTERTOXIN II AS A SELECTIVE INHIBITOR OF EWING FAMILY OF TUMOR CELLS
    Publication number: 20200101038
    Abstract: Certain embodiments are directed to methods for treating Ewing family tumors (EFT) comprising administering an effective amount of altertoxin II to a subject having EFT.
    Type: Application
    Filed: December 20, 2017
    Publication date: April 2, 2020
    Applicants: The Board of Regents of the University of Texas System, The Board of Regents of the University of Oklahoma System
    Inventors: Susan L MOOBERRY, Andrew J ROBLES, April L RISINGER, Robert H CICHEWICZ, Salkat HALDAR, Peter HOUGHTON